Details of the Drug Reposition

General Information of This Drug (ID: DMKA2FL)

Drug Name
CD19/CD22 CAR T-Cells   DMKA2FL
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
leukaemia DISS7D1V 2A60-2B33 Phase 1 [1]
B-cell prolymphocytic leukaemia DISUPB11 2A82.1 Phase 1 [1]
B-cell lymphoma DISIH1YQ 2A86 Phase 1 [1]
Non-hodgkin lymphoma DISS2Y8A 2B33.5 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03448393) CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies